Skip to main content

Advertisement

Springer Nature Link
Log in

Antibiotic-associated vulvovaginal candidiasis

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Vulvovaginal candidiasis (VVC) is one of the most common causes of vaginitis, and its incidence has increased markedly during the past three decades. The widespread overuse of antibiotics has been suggested as one of the major factors contributing to the increasing incidence of VVC. However, evidence supporting this association has been limited because few studies with rigorous scientific methodology have been conducted. Moreover, existing data regarding the risk for developing VVC after antibiotic use are conflicting. This review examines the available information in the literature regarding antibiotic-associated VVC, its incidence, and its potential mechanisms. Implications for clinical practice and research are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Sobel JD, Faro S, Force RW, et al.: Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998, 178:203–211. This is a useful overview of VVC in general.

    Article  PubMed  CAS  Google Scholar 

  2. Reed BD: Risk factors for Candida vulvovaginitis. Obstet Gynecol Surv 1992, 47:551–560.

    Article  PubMed  CAS  Google Scholar 

  3. Monif GR: Classification and pathogenesis of vulvovaginal candidiasis. Am J Obstet Gynecol 1985, 152:935–939.

    PubMed  CAS  Google Scholar 

  4. Weisberg M: Considerations in therapy for vulvovaginal candidiasis: when and whom to treat. In Clinical Perspectives: Terconazole, an Advance in Vulvovaginal Candidiasis Therapy, vol 51. Edited by Sobel JD. New York: McGraw-Hill; 1988:1–8.

    Google Scholar 

  5. Hurley R: Candidal vaginitis. Proc R Soc Med 1977, 70(Suppl):1–2.

    PubMed  Google Scholar 

  6. Hurley R, De Louvois J: Candida vaginitis. Postgrad Med J 1979, 55:645–647.

    PubMed  CAS  Google Scholar 

  7. Hurley R: Recurrent Candida infection. Clin Obstet Gynaecol 1981, 8:209–214.

    PubMed  CAS  Google Scholar 

  8. Sobel JD: Candidal vulvovaginitis. Clin Obstet Gynecol 1993, 36:153–165.

    Article  PubMed  CAS  Google Scholar 

  9. Sobel JD: Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985, 152:924–935.

    PubMed  CAS  Google Scholar 

  10. Ferris DG, Nyirjesy P, Sobel JD, et al.: Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002, 99:419–425.

    Article  PubMed  Google Scholar 

  11. Foxman B, Barlow R, D’Arcy H, et al.: Candida vaginitis: selfreported incidence and associated costs. Sex Transm Dis 2000, 27:230–235.

    Article  PubMed  CAS  Google Scholar 

  12. Bluestein D, Rutledge C, Lumsden L: Predicting the occurrence of antibiotic-induced candidal vaginitis (AICV). Fam Pract Res J 1991, 11:319–326. This is a prospective case study of women using a variety of antibiotics who were determined to have increased asymptomatic vaginal Candida colonization; some of them developed symptomatic VVC.

    PubMed  CAS  Google Scholar 

  13. Odds FC: Candida and Candidosis, edn 2. London: Balliere Tindall; 1988. This is a very comprehensive review of literature on all aspects of Candida and candidosis, including VVC and antibiotic-associated VVC.

    Google Scholar 

  14. Odds FC: Genital candidosis. Clin Exp Dermatol 1982, 7:345–354.

    Article  PubMed  CAS  Google Scholar 

  15. Eschenbach D: Lower genital tract infections. In Infectious Diseases in the Female Patient. Edited by Galask RP. New York: Springer-Verlag; 1986:163–186.

    Google Scholar 

  16. Horowitz BJ, Giaquinta D, Ito S: Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992, 32:248–255.

    PubMed  CAS  Google Scholar 

  17. Caruso L: Vaginal moniliasis after tetracycline therapy. Am J Obstet Gynecol 1964, 90:374–380. This prospective, double-blind experimental study, which compared tetracycline with tetracycline and amphotericin B combination therapy for vaginal Candida colonization with a total of 3 weeks’ followup at 1 week interval, found progressively increased vaginal Candida colonization.

    PubMed  CAS  Google Scholar 

  18. Oriel JD, Waterworth PM: Effects of minocycline and tetracycline on the vaginal yeast flora. J Clin Pathol 1975, 28:403–406. This prospective, randomized experimental study, which compared tetracycline with minocycline for vaginal Candida colonization with a total 2 of weeks follow-up at 1 week interval, found increased vaginal Candida colonization.

    PubMed  CAS  Google Scholar 

  19. MacDonald TM, Beardon PH, McGilchrist MM, et al.: The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. Q J Med 1993, 86:419–424.

    PubMed  CAS  Google Scholar 

  20. Spinillo A, Capuzzo E, Acciano S, et al.: Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis. Am J Obstet Gynecol 1999, 180:14–17.

    Article  PubMed  CAS  Google Scholar 

  21. Iravani A, Richard GA: Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora. Antimicrob Agents Chemother 1986, 29:107–111.

    PubMed  CAS  Google Scholar 

  22. Silverman M, Okun R: Oxytetracycline-nystatin in the prevention of candidal vaginitis. Am J Obstet Gynecol 1971, 111:398–404.

    PubMed  CAS  Google Scholar 

  23. Miettinen A, Laine S, Teisala K, Heinonen PK: The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease. Arch Gynecol Obstet 1991, 249:95–101.

    Article  PubMed  CAS  Google Scholar 

  24. Willmott FE: Genital yeasts in female patients attending a VD clinic. Br J Vener Dis 1975, 51:119–124.

    PubMed  CAS  Google Scholar 

  25. Davis BA: Vaginal moniliasis in private practice. Obstet Gynecol 1969, 34:40–45.

    PubMed  CAS  Google Scholar 

  26. Geiger AM, Foxman B: Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 1996, 7:182–187.

    Article  PubMed  CAS  Google Scholar 

  27. Reed BD, Huck W, Zazove P: Differentiation of Gardnerella vaginalis, Candida albicans, and Trichomonas vaginalis infections of the vagina. J Fam Pract 1989, 28:673–680.

    PubMed  CAS  Google Scholar 

  28. Leegaard M: The incidence of Candida albicans in the vagina of "healthy young women". How often do they have symptoms? Possible etiological factors. Acta Obstet Gynecol Scand 1984, 63:85–89.

    Article  PubMed  CAS  Google Scholar 

  29. Spinillo A, Capuzzo E, Nicola S, et al.: The impact of oral contraception on vulvovaginal candidiasis. Contraception 1995, 51:293–297.

    Article  PubMed  CAS  Google Scholar 

  30. Glover DD, Larsen B: Longitudinal investigation of candida vaginitis in pregnancy: role of superimposed antibiotic use. Obstet Gynecol 1998, 91:115–118. This recent, large prospective cohort study of pregnant women had a surprising result: women administered antibiotics during pregnancy had a lower rate of subsequent symptomatic vaginal yeast infection than women who had not been administered antibiotics.

    Article  PubMed  CAS  Google Scholar 

  31. Burns DN, Tuomala R, Chang BH, et al.: Vaginal colonization or infection with Candida albicans in human immunodeficiency virus-infected women during pregnancy and during the postpartum period. Women and Infants Transmission Study Group. Clin Infect Dis 1997, 24:201–210. In this study, a cohort of pregnant women with HIV infection were monitored during the antepartum and postpartum periods. Antibiotics were determined to be a risk factor for yeast infection in the postpartum period but not the antepartum period.

    PubMed  CAS  Google Scholar 

  32. Larsen B: Microbiology of the female genital tract. In Obstetric and Gynecologic Infectious Disease. Edited by Pastorek JG II. New York: Raven Press; 1994:11–25.

    Google Scholar 

  33. Savage DC: Localization of certain indigenous microorganisms on the ileal villi of rats. J Bacteriol 1969, 97:1505–1506.

    PubMed  CAS  Google Scholar 

  34. Agnew KJ, Hillier SL: The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli. Sex Transm Dis 1995, 22:269–273.

    Article  PubMed  CAS  Google Scholar 

  35. Sobel JD, Chaim W: Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol 1996, 34:2497–2499.

    PubMed  CAS  Google Scholar 

  36. Hawes SE, Hillier SL, Benedetti J, et al.: Hydrogen peroxideproducing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996, 174:1058–1063.

    PubMed  CAS  Google Scholar 

  37. Auger P, Joly J: Microbial flora associated with Candida albicans vulvovaginitis. Obstet Gynecol 1980, 55:397–401.

    PubMed  CAS  Google Scholar 

  38. Moore M: In vivo and in vitro effect of aureomycin hydrocholoride on Syringospore (Monilia, Candida) albicans. J Lab Clin Med 1951, 37:703–712.

    PubMed  CAS  Google Scholar 

  39. Hupert M: Pathogenesis of Candida albicans infection following antibiotic therapy. J Bacteriol 1953, 65:171–176.

    Google Scholar 

  40. Waterworth PM: The effect of minocycline on Candida albicans. J Clin Pathol 1974, 27:269–272.

    PubMed  CAS  Google Scholar 

  41. Witkin SS: Immunologic factors influencing susceptibility to recurrent candidal vaginitis. Clin Obstet Gynecol 1991, 34:662–668.

    Article  PubMed  CAS  Google Scholar 

  42. Sjoberg I, Grahn E, Hakansson S, Holm SE: Influence of phenoxymethylpenicillin on the vaginal ecosystem. Gynecol Obstet Invest 1992, 33:42–46.

    Article  PubMed  CAS  Google Scholar 

  43. Grossman JH 3rd, Adams RL: Vaginal flora in women undergoing hysterectomy with antibiotic prophylaxis. Obstet Gynecol 1979, 53:23–26.

    PubMed  Google Scholar 

  44. Ohm MJ, Galask RP: The effect of antibiotic prophylaxis on patients undergoing vaginal operations. II. Alterations of microbial flora. Am J Obstet Gynecol 1975, 123:597–604.

    PubMed  CAS  Google Scholar 

  45. Ohm MJ, Galask RP: The effect of antibiotic prophylaxis on patients undergoing vaginal operations. I. The effect on morbidity. Am J Obstet Gynecol 1975, 123:590–596.

    PubMed  CAS  Google Scholar 

  46. Therapy of candidal vaginitis: the effect of eliminating intestinal Candida. Nystatin Multicenter Study Group. Am J Obstet Gynecol 1986, 155:651–655.

  47. Fong IW: The rectal carriage of yeast in patients with vaginal candidiasis. Clin Invest Med 1994, 17:426–431.

    PubMed  CAS  Google Scholar 

  48. Fitzpatrick JJ, Topley HE: Ampicillin therapy and Candida outgrowth. Am J Med Sci 1966, 252:310–313.

    Article  PubMed  CAS  Google Scholar 

  49. McVay L, Sprunt DH: A study of moniliasis in aureomycin therapy. Proc Soc Exper Biol Med 1951, 78:759–761.

    CAS  Google Scholar 

  50. Hart G: Factors associated with trichomoniasis, candidiasis and bacterial vaginosis. Int J STD AIDS 1993, 4:21–25.

    PubMed  CAS  Google Scholar 

  51. Fine JS, Jacobson MS: Single-dose versus conventional therapy of urinary tract infections in female adolescents. Pediatrics 1985, 75:916–920.

    PubMed  CAS  Google Scholar 

  52. Leigh DA, Joy GE, Tait S, et al.: Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil. J Antimicrob Chemother 1989, 23:267–273.

    Article  PubMed  CAS  Google Scholar 

  53. Menday AP: Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection. Int J Antimicrob Agents 2002, 20:297–300.

    Article  PubMed  CAS  Google Scholar 

  54. Gilgor RS: Complications of tetracycline therapy for acne. N C Med J 1972, 33:331–333.

    PubMed  CAS  Google Scholar 

  55. Hall JH, Lupton ES: Tetracycline therapy for acne: incidence of vaginitis. Cutis 1977, 20:97–98.

    PubMed  CAS  Google Scholar 

  56. McKendrick AJ, Wilson MI, Main DM: Oral Candida and longterm tetracycline therapy. Arch Oral Biol 1967, 12:281–290.

    Article  PubMed  CAS  Google Scholar 

  57. Wilton L: The relative risk of vaginal candidiasis, in women in England aged >16 years, included in the prescription event monitoring studies of six antibiotics and of six antidepressant drugs. Drug Safety 2003, In press.

  58. Ferrer J: Vaginal candidosis: epidemiological and etiological factors. Int J Gynaecol Obstet 2000, 71(Suppl 1):S21-S27.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 101 East Alexandrine, 2nd floor, 48201, Detroit, MI, USA

    Jinping Xu MD, MS

Authors
  1. Jinping Xu MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jack D. Sobel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, J., Sobel, J.D. Antibiotic-associated vulvovaginal candidiasis. Curr Infect Dis Rep 5, 481–487 (2003). https://doi.org/10.1007/s11908-003-0091-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-003-0091-x

Keywords

Search

Navigation